Onchocerciasis

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2009, Pages 1379-1400

  Lustigman, Sara ^a   Abraham, David ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884434818     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00067-6     Document Type: Chapter

References (167)

1. Abiose A., Homeida M., Liese B., Molyneux D., Remme H. Onchocerciasis control strategies. Lancet 2000, 356:1523-1524.
2. Abraham D., Lange A.M., Yutanawiboonchai W., Trpis M., Dickerson J.W., Swenson B., Eberhard M.L. Survival and development of larval Onchocerca volvulus in diffusion chambers implanted in primate and rodent hosts. J. Parasitol. 1993, 79:571-582.
3. Abraham D., Leon O., Leon S., Lustigman S. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus. Infect. Immun. 2001, 69:262-270.
4. Abraham D., Leon O., Schnyder-Candrian S., Wang C.C., Galioto A.M., Kerepesi L.A., Lee J.J., Lustigman S. Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae. Infect. Immun. 2004, 72:810-817.
5. Abraham D., Lucius R., Trees A.J. Immunity to Onchocerca spp. in animal hosts. Trends Parasitol. 2002, 18:164-171.
6. Achukwi M.D., Harnett W., Enyong P., Renz A. Successful vaccination against Onchocerca ochengi infestation in cattle using live Onchocerca volvulus infective larvae. Parasite Immunol. 2007, 29:113-116.
7. Adam R., Kaltmann B., Rudin W., Friedrich T., Marti T., Lucius R. Identification of chitinase as the immunodominant filarial antigen recognized by sera of vaccinated rodents. J. Biol. Chem. 1996, 271:1441-1447.
8. Anand S.B., Krithika K.N., Murugan V., Reddy M.V., Kaliraj P. Comparison of immuno prophylactic efficacy of Bm rALT2 or Bm rVAH or rALT+VAH by single and multiple antigen vaccination mode. Am. Soc. Trop. Med. Hyg. 2006, 75:295.
9. Ardelli B.F., Guerriero S.B., Prichard R.K. Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein. Mol. Biochem. Parasitol. 2005, 143:58-66.
10. Ardelli B.F., Guerriero S.B., Prichard R.K. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity. Parasitology 2006, 132:375-386.
11. Ardelli B.F., Guerriero S.B., Prichard R.K. Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 2006, 145:94-100.
12. Ardelli B.F., Prichard R.K. Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa. Ann. Trop. Med. Parasitol. 2004, 98:371-384.
13. Awadzi K., Attah S.K., Addy E.T., Opoku N.O., Quartey B.T., Lazdins-Helds J.K., Ahmed K., Boatin B.A., Boakye D.A., Edwards G. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two -onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 2004, 98:359-370.
14. Awadzi K., Boakye D.A., Edwards G., Opoku N.O., Attah S.K., Osei-Atweneboana M.Y., Lazdins-Helds J.K., Ardrey A.E., Addy E.T., Quartey B.T., Ahmed K., Boatin B.A., Soumbey-Alley E.W. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 2004, 98:231-249.
15. Basáñez M.G., Pion S.D., Churcher T.S., Breitling L.P., Little M.P., Boussinesq M. River blindness: a success story under threat?. PLoS Med. 2006, 3(9):e371. doi:10.1371/journal.pmed.0030371.
16. Bianco A.E., Luty A., Whitworth J., Taylor D. Immunity to Onchocerca volvulus microfilariae in mice and the induction of cross-protection with O. lienalis. Trop. Med. Parasitol. 1991, 42:188-190.
17. Boatin B.A., Richards F.O. Control of onchocerciasis. Adv. Parasitol. 2006, 61:349-394.
18. Bourguinat, C., Pion, S.D.S., Kamgno, J., Gardon, J., Duke, B.O., Boussinesq, M. and Prichard, R.K. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis., 2007; Aug 30 1(1) e72
19. Bourguinat C., Pion S.D., Kamgno J., Gardon J., Gardon-Wendel N., Duke B.O., Prichard R.K., Boussinesq M. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naive patients from Cameroon, and its relationship with fertility of the worms. Parasitology 2006, 132:1-8.
20. Boussinesq M., Prod'hon J., Chippaux J.P. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:82-86.
21. Boyer A.E., Tsang V.C., Eberhard M.L., Zea-Flores G., Hightower A., Pilcher J.B., Zea-Flores R., Zhou W., Reimer C.B. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens. J. Immunol. 1991, 146:4001-4010.
22. Bradley J.E., Elson L., Tree T.I., Stewart G., Guderian R., Calvopina M., Paredes W., Araujo E., Nutman T.B. Resistance to Onchocerca volvulus: differential cellular and humoral responses to a recombinant antigen, OvMBP20/11. J. Infect. Dis. 1995, 172:831-837.
23. Brattig N.W. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes Infect. 2004, 6:113-128.
24. Brattig N.W., Bazzocchi C., Kirschning C.J., Reiling N., Buttner D.W., Ceciliani F., Geisinger F., Hochrein H., Ernst M., Wagner H., Bandi C., Hoerauf A. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J. Immunol. 2004, 173:437-445.
25. Brattig N.W., Buttner D.W., Hoerauf A. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect. 2001, 3:439-446.
26. Brattig N.W., Rathjens U., Ernst M., Geisinger F., Renz A., Tischendorf F.W. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes. Microbes Infect. 2000, 2:1147-1157.
27. Buttner D.W., Racz P. Macro- and microfilariae in nodules from onchocerciasis patients in the Yemen Arab Republic. Tropenmed. Parasitol. 1983, 34:113-121.
28. Carlow C.K., Bianco A.E. Resistance to Onchocerca lienalis microfilariae in mice conferred by egg antigens of homologous and heterologous Onchocerca species. Parasitology 1987, 94:485-496.
29. Carlow C.K., Muller R., Bianco A.E. Further studies on the resistance to Onchocerca microfilariae in CBA mice. Trop. Med. Parasitol. 1986, 37:276-281.
30. Collins R.C., Gonzales-Peralta C., Castro J., Zea-Flores G., Cupp M.S., Richards F.O., Cupp E.W. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am. J. Trop. Med. Hyg. 1992, 47:156-169.
31. Cook J.A., Steel C., Ottesen E.A. Towards a vaccine for onchocerciasis. Trends Parasitol. 2001, 17:555-558.
32. Cross H.F., Haarbrink M., Egerton G., Yazdanbakhsh M., Taylor M.J. Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet 2001, 358:1873-1875.
33. Dadzie Y., Neira M., Hopkins D. Final report of the Conference on the Eradicability of Onchocerciasis. Filaria J. 2003, 2:2.
34. Day K.P., Gregory W.F., Maizels R.M. Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol. 1991, 13:277-290.
35. Duke B.O. Observations on Onchocerca volvulus in experimentally infected chimpanzees. Tropenmed. Parasitol. 1980, 31:41-54.
36. Duke B.O., Moore P.J. The contributions of different age groups to the transmission of Onchocerciasis in a Cameroon forest village. Trans. R. Soc. Trop. Med. Hyg. 1968, 62:22-28.
37. Eberhard M.L., Dickerson J.W., Boyer A.E., Tsang V.C., Zea-Flores R., Walker E.M., Richards F.O., Zea-Flores G., Strobert E. Experimental Onchocerca volvulus infections in mangabey monkeys ( Cercocebus atys) compared to infections in humans and chimpanzees ( Pan troglodytes). Am. J. Trop. Med. Hyg. 1991, 44:151-160.
38. Eberhard M.L., Dickerson J.W., Tsang V.C., Walker E.M., Ottesen E.A., Chandrashekar R., Weil G.J., Trpis M., Strobert E., Constantinidis I., Swenson R.B. Onchocerca -volvulus: parasitologic and serologic responses in experimentally infected chimpanzees and mangabey monkeys. Exp. Parasitol. 1995, 80:454-462.
39. Eisenbeiss W.F., Apfel H., Meyer T.F. Protective immunity linked with a distinct developmental stage of a filarial parasite. J. Immunol. 1994, 152:735-742.
40. Ejere H., Schwartz E., Wormald R. Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst. Rev. 2001, 2001:CD002219.
41. Ellis L.A., Reason A.J., Morris H.R., Dell A., Iglesias R., Ubeira F.M., Appleton J.A. Glycans as targets for monoclonal antibodies that protect rats against Trichinella spiralis. Glycobiology 1994, 4:585-592.
42. Elson L.H., Guderian R.H., Araujo E., Bradley J.E., Days A., Nutman T.B. Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador. J. Infect. Dis. 1994, 169:588-594.
43. Eng J.K., Blackhall W.J., Osei-Atweneboana M.Y., Bourguinat C., Galazzo D., Beech R.N., Unnasch T.R., Awadzi K., Lubega G.W., Prichard R.K. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol. 2006, 150:229-235.
44. Eng J.K., Prichard R.K. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol. Biochem. Parasitol. 2005, 142:193-202.
45. Faulkner H., Gardon J., Kamgno J., Enyong P., Boussinesq M., Bradley J.E. Antibody responses in onchocerciasis as a function of age and infection intensity. Parasite Immunol. 2001, 23:509-516.
46. Folkard S.G., Hogarth P.J., Taylor M.J., Bianco A.E. Eosinophils are the major effector cells of immunity to microfilariae in a mouse model of onchocerciasis. Parasitology 1996, 112:323-329.
47. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996, 271:1728-1730.
48. Frand A.R., Russel S., Ruvkun G. Functional genomic analysis of C. elegans molting. PLoS Biol. 2005, 3:e312.
49. Frank G.R., Tripp C.A., Grieve R.B. Molecular cloning of a developmentally regulated protein isolated from excretory-secretory products of larval Dirofilaria immitis. Mol. Biochem. Parasitol. 1996, 75:231-240.
50. Gallin M., Edmonds K., Ellner J.J., Erttmann K.D., White A.T., Newland H.S., Taylor H.R., Greene B.M. Cell-mediated immune responses in human infection with Onchocerca volvulus. J. Immunol. 1988, 140:1999-2007.
51. Ghedin E., Wang S., Foster J.M., Slatko B.E. First sequenced genome of a parasitic nematode. Trends Parasitol. 2004, 20:151-153.
52. Ghosh K., Hawdon J., Hotez P. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm ( Ancylostoma caninum) larvae. J. Infect. Dis. 1996, 174:1380-1383.
53. Goud G.N., Bottazzi M.E., Zhan B., Mendez S., Deumic V., Plieskatt J., Liu S., Wang Y., Bueno L., Fujiwara R., Samuel A., Ahn S.Y., Solanki M., Asojo O.A., Wang J., Bethony J.M., Loukas A., Roy M., Hotez P.J. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine 2005, 23:4754-4764.
54. Goud G.N., Zhan B., Ghosh K., Loukas A., Hawdon J., Dobardzic A., Deumic V., Liu S., Dobardzic R., Zook B.C., Jin Q., Liu Y., Hoffman L., Chung-Debose S., Patel R., Mendez S., Hotez P.J. Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J. Infect. Dis. 2004, 189:919-929.
55. Greene B.M., Gbakima A.A., Albiez E.J., Taylor H.R. Humoral and cellular immune responses to Onchocerca volvulus infection in humans. Rev. Infect. Dis. 1985, 7:789-795.
56. Gregory W.F., Atmadja A.K., Allen J.E., Maizels R.M. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect. Immun. 2000, 68:4174-4179.
57. Harnett W., Bradley J.E., Garate T. Molecular and immunodiagnosis of human filarial nematode infections. Parasitology 1998, 117(Suppl):S59-S71.
58. Harrison R.A., Wu Y., Egerton G., Bianco A.E. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice. Vaccine 1999, 18:647-655.
59. Hashmi S., Tawe W., Lustigman S. Caenorhabditis elegans and the study of gene function in parasites. Trends Parasitol. 2001, 17:387-393.
60. Henkle-Duhrsen K., Kampkotter A. Antioxidant enzyme families in parasitic nematodes. Mol. Biochem. Parasitol. 2001, 114:129-142.
61. Higazi T.B., Filiano A., Katholi C.R., Dadzie Y., Remme J.H., Unnasch T.R. Wolbachia endosymbiont levels in severe and mild strains of Onchocerca volvulus. Mol. Biochem. Parasitol. 2005, 141:109-112.
62. Hoch B., Wahl G., Enyong P., Luder C.G.K., Harnett W., Renz A. Serological recognition of specific and crossreactive of O. ochengi and O. volvulus by infected cattle and humans. Trop. Med. Parasitol. 1992, 43:206-207.
63. Hoerauf A., Brattig N. Resistance and susceptibility in human onchocerciasis-beyond Th1 vs. Th2. Trends Parasitol. 2002, 18:25-31.
64. Hoerauf A., Mand S., Volkmann L., Buttner M., Marfo-Debrekyei Y., Taylor M., Adjei O., Buttner D.W. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect. 2003, 5:261-273.
65. Hoerauf A., Steel C. Towards a strategic plan for research to support the global program to eliminate lymphatic filariasis-3.2 protective immunity-vaccines. Am. J. Trop. Med. Hyg. 2004, 71(Suppl):34-36.
66. Hogarth P.J., Bianco A.E. Interleukin-12 modulates T-cell responses to microfilariae but fails to abrogate interleukin-5-dependent immunity in a mouse model of onchocerciasis. Immunology 1999, 98:406-412.
67. Hogarth P.J., Bianco A.E. IL-5 dominates cytokine responses during expression of protective immunity to Onchocerca lienalis microfilariae in mice. Parasite Immunol. 1999, 21:81-88.
68. Hogarth P.J., Folkard S.G., Taylor M.J., Bianco A.E. Accelerated clearance of Onchocerca microfilariae and resistance to reinfection in interleukin-4 gene knockout mice. Parasite Immunol. 1995, 17:653-657.
69. Hogarth P.J., Taylor M.J., Bianco A.E. IL-5-dependent immunity to microfilariae is independent of IL-4 in a mouse model of onchocerciasis. J. Immunol. 1998, 160:5436-5440.
70. Horauf A., Fleischer B. Immune responses to filarial infection in laboratory mice. Med. Microbiol. Immunol. (Berl.) 1997, 185:207-215.
71. Hotez P.J. Control of onchocerciasis-the next generation. Lancet 2007, 369:1979-1980.
72. Hotez P.J., Bethony J., Bottazzi M.E., Brooker S., Diemert D., Loukas A. New technologies for the control of human hookworm infection. Trends Parasitol. 2006, 22:327-331.
73. Hotez P.J., Ferris M.T. The antipoverty vaccines. Vaccine 2006, 24:5787-5799.
74. Huang Y.J., Prichard R.K. Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Mol. Biochem. Parasitol. 1999, 102:273-281.
75. Irvine M., Johnson E.H., Lustigman S. Identification of larval-stage-specific antigens of Onchocerca volvulus uniquely recognized by putative immune sera from humans and vaccination sera from animal models. Ann. Trop. Med. Parasitol. 1997, 91:67-77.
76. Jenkins R.E., Taylor M.J., Gilvary N., Bianco A.E. Characterization of a secreted antigen of Onchocerca volvulus with host-protective potential. Parasite Immunol. 1996, 18:29-42.
77. Johnson E.H., Irvine M., Kass P.H., Browne J., Abdullai M., Prince A.M., Lustigman S. Onchocerca volvulus: in vitro cytotoxic effects of human neutrophils and serum on third-stage larvae. Trop. Med. Parasitol. 1994, 45:331-335.
78. Johnson E.H., Schynder-Candrian S., Rajan T.V., Nelson F.K., Lustigman S., Abraham D. Immune responses to third stage larvae of Onchocerca volvulus in interferon-gamma and interleukin-4 knockout mice. Parasite Immunol. 1998, 20:319-324.
79. Joseph G.T., Huima T., Lustigman S. Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1. Mol. Biochem. Parasitol. 1998, 96:177-183.
80. Joseph G.T., McCarthy J.S., Huima T., Mair K.F., Kass P.H., Boussinesq M., Goodrick L., Bradley J.E., Lustigman S. Onchocera volvulus: characterization of a highly immunogenic Gln-rich protein. Mol. Biochem. Parasitol. 1997, 90:55-68.
81. Keiser P.B., Reynolds S.M., Awadzi K., Ottesen E.A., Taylor M.J., Nutman T.B. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J. Infect. Dis. 2002, 185:805-811.
82. Kenney J.S., Hughes B.W., Masada M.P., Allison A.C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods 1989, 121:157-166.
83. Kerepesi L.A., Leon O., Lustigman S., Abraham D. Protective immunity to the larval stages of Onchocerca volvulus is dependent on toll-like receptor 4. Infect. Immun. 2005, 73:8291-8297.
84. Kohler P. The biochemical basis of anthelmintic action and resistance. Int. J. Parasitol. 2001, 31:336-345.
85. Kurniawan-Atmadja A., Sartono E., Partono F., Yazdanbakhsh M., Maizels R.M. Antibody responses to filarial infective larvae are not dominated by the IgG4 isotype. Parasite Immunol. 1998, 20:9-17.
86. Lange A.M., Yutanawiboonchai W., Lok J.B., Trpis M., Abraham D. Induction of protective immunity against larval Onchocerca volvulus in a mouse model. Am. J. Trop. Med. Hyg. 1993, 49:783-788.
87. Lange A.M., Yutanawiboonchai W., Scott P., Abraham D. IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. J. Immunol. 1994, 153:205-211.
88. Le Goff L., Martin C., Oswald I.P., Vuong P.N., Petit G., Ungeheuer M.N., Bain O. Parasitology and immunology of mice vaccinated with irradiated Litomosoides sigmodontis larvae. Parasitology 2000, 120:271-280.
89. Leke R.G., Boto W.M., Lando G., Ngu J.L. Immunity to Onchocerca volvulus. Serum mediated leucocyte adherence to infective larvae in vitro. Trop. Med. Parasitol. 1989, 40:39-41.
90. Lipner E.M., Dembele N., Souleymane S., Alley W.S., Prevots D.R., Toe L., Boatin B., Weil G.J., Nutman T.B. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J. Infect. Dis. 2006, 194:216-221.
91. Lizotte-Waniewski M., Tawe W., Guiliano D.B., Lu W., Liu J., Williams S.A., Lustigman S. Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries. Infect. Immun. 2000, 68:3491-3501.
92. Lucius R., Textor G., Kern A., Kirsten C. Acanthocheilonema viteae: vaccination of jirds with irradiation-attenuated stage-3 larvae and with exported larval antigens. Exp. Parasitol. 1991, 73:184-196.
93. Luder C.G., Schulz-Key H., Banla M., Pritze S., Soboslay P.T. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease. Clin. Exp. Immunol. 1996, 105:245-253.
94. Luder C.G., Soboslay P.T., Prince A.M., Greene B.M., Lucius R., Schulz-Key H. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae. Parasitology 1993, 107:87-97.
95. Lustigman S., Brotman B., Huima T., Prince A.M. Characterization of an Onchocerca volvulus cDNA clone encoding a genus specific antigen present in infective larvae and adult worms. Mol. Biochem. Parasitol. 1991, 45:65-75.
96. Lustigman S., Brotman B., Huima T., Prince A.M., McKerrow J.H. Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J. Biol. Chem. 1992, 267:17339-17346.
97. Lustigman S., Brotman B., Johnson E.H., Smith A.B., Huima T., Prince A.M. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a microfilarial surface-associated antigen. Mol. Biochem. Parasitol. 1992, 50:79-93.
98. Lustigman S., James E.R., Tawe W., Abraham D. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends Parasitol. 2002, 18:135-141.
99. Lustigman S., MacDonald A.J., Abraham D. CD4+ dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions. J. Int. Parasitol. 2003, 33:1161-1171.
100. Lustigman S., McKerrow J.H., Shah K., Lui J., Huima T., Hough M., Brotman B. Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae. J. Biol. Chem. 1996, 271:30181-30189.
101. MacDonald A.J., Tawe W., Leon O., Cao L., Liu J., Oksov Y., Abraham D., Lustigman S. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity. Parasite Immunol. 2004, 26:53-62.
102. MacDonald A.J., Turaga P.S., Harmon-Brown C., Tierney T.J., Bennett K.E., McCarthy M.C., Simonek S.C., Enyong P.A., Moukatte D.W., Lustigman S. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infect. Immun. 2002, 70:2796-2804.
103. Mackenzie C.D., Williams J.F., Sisley B.M., Steward M.W., O'Day J. Variations in host responses and the pathogenesis of human onchocerciasis. Rev. Infect. Dis. 1985, 7:802-808.
104. McCarthy J.S., Nutman T.B. Perspective: prospects for develop-ment of vaccines against human helminth infections. J. Infect. Dis. 1996, 174:1384-1390.
105. McCarthy J.S., Wieseman M., Tropea J., Kaslow D., Abraham D., Lustigman S., Tuan R., Guderian R.H., Nutman T.B. Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infect. Immun. 2002, 70:851-858.
106. McVay C.S., Bracken P., Gagliardo L.F., Appleton J. Antibodies to tyvelose exhibit multiple modes of interference with the epithelial niche of Trichinella spiralis. Infect. Immun. 2000, 68:1912-1918.
107. McVay C.S., Tsung A., Appleton J. Participation of parasite surface glycoproteins in antibody-mediated protection of epithelial cells against Trichinella spiralis. Infect. Immun. 1998, 66:1941-1945.
108. Molyneux D.H. Onchocerciasis control in West Africa: current status and future of the Onchocerciasis Control Programme. Parasitol. Today 1995, 11:399-402.
109. Nfon C.K., Makepeace B.L., Njongmeta L.M., Tanya V.N., Trees A.J. Lack of resistance after re-exposure of cattle cured of Onchocerca ochengi infection with oxytetracycline. Am. J. Trop. Med. Hyg. 2007, 76:67-72.
110. Ngoumou P., Walsh J.F., Mace J.M. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann. Trop. Med. Parasitol. 1994, 88:463-474.
111. Njongmeta L.M., Nfon C.K., Gilbert J., Makepeace B.L., Tanya V.N., Trees A.J. Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal. Int. J. Parasitol. 2004, 34:1069-1074.
112. Noma M., Nwoke B.E., Nutall I., Tambala P.A., Enyong P., Namsenmo A., Remme J., Amazigo U.V., Kale O.O., Seketeli A. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann. Trop. Med. Parasitol. 2002, 96(Suppl 1):S29-S39.
113. Nutman T.B. Future directions for vaccine-related onchocerciasis research. Trends Parasitol. 2002, 18:237-239.
114. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., Gyapong J.O., Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007, 369:2021-2029.
115. Ottesen E.A. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 1995, 171:659-671.
116. Ozoh G., Boussinesq M., Bissek A.C., Kobangue L., Kombila M., Mbina J.R., Enyong P., Noma M., Seketeli A., Fobi G. Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop. Med. Int. Health 2007, 12:123-129.
117. Pearlman E., Gillette-Ferguson I. Onchocerca volvulus, Wolbachia and river blindness. Chem. Immunol. Allergy 2007, 92:254-265.
118. Peters D.H., Phillips T. Mectizan Donation Program: evaluation of a public-private partnership. Trop. Med. Int. Health 2004, 9:A4-A15.
119. Pfaff A.W., Schulz-Key H., Soboslay P.T., Taylor D.W., MacLennan K., Hoffmann W.H. Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis. Int. J. Parasitol. 2002, 32:171-178.
120. Pischke S., Buttner D.W., Liebau E., Fischer P. An internal control for the detection of Onchocerca volvulus DNA by PCR-ELISA and rapid detection of specific PCR products by DNA detection test strips. Trop. Med. Int. Health 2002, 7:526-531.
121. Prince A.M., Brotman B., Johnson E.H., Smith A., Pascual D., Lustigman S. Onchocerca volvulus: immunization of chimpanzees with X-irradiated third-stage (L3) larvae. Exp. Parasitol. 1992, 74:239-250.
122. Ramachandran S., Kumar M.P., Rami R.M., Chinnaiah H.B., Nutman T., Kaliraj P., McCarthy J. The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination. Microbiol. Immunol. 2004, 48:945-955.
123. Remme J.H.F. The African Programme for Onchocerciasis Control: preparing to launch. Parasitol. Today 1995, 11:403-406.
124. Richards F.O., Boatin B., Sauerbrey M., Seketeli A. Control of onchocerciasis today: status and challenges. Trends Parasitol. 2001, 17:558-563.
125. Rodriguez-Perez M.A., Katholi C.R., Hassan H.K., Unnasch T.R. Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico. Am. J. Trop. Med. Hyg. 2006, 74:1026-1033.
126. Saint Andre A., Blackwell N.M., Hall L.R., Hoerauf A., Brattig N.W., Volkmann L., Taylor M.J., Ford L., Hise A.G., Lass J.H., Diaconu E., Pearlman E. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 2002, 295:1892-1895.
127. Sartono E., Kruize Y.C., Kurniawan A., Maizels R.M., Yazdanbakhsh M. Depression of antigen-specific interleukin-5 and interferon-gamma responses in human lymphatic filariasis as a function of clinical status and age. J. Infect. Dis. 1997, 175:1276-1280.
128. Schulz-Key H. Observations on the reproductive biology of Onchocerca volvulus. Acta Leiden. 1990, 59:27-44.
129. Sher A. Vaccination against parasites: special problems imposed by the adaptation of parasitic organisms to the host immune response. The Biology of Parasitism 1988, 169-182. Alan R. Liss. P.T. Englund, A. Sher (Eds.).
130. Soboslay P.T., Dreweck C.M., Taylor H.R., Brotman B., Wenk P., Greene B.M. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection. J. Immunol. 1991, 147:346-353.
131. Soboslay P.T., Geiger S.M., Weiss N., Banla M., Luder C.G., Dreweck C.M., Batchassi E., Boatin B.A., Stadler A., Schulz-Key H. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology 1997, 90:592-599.
132. Soboslay P.T., Luder C.G., Hoffmann W.H., Michaelis I., Helling G., Heuschkel C., Dreweck C.M., Blanke C.H., Pritze S., Banla M., et al. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin. Exp. Immunol. 1994, 96:238-244.
133. Soboslay P.T., Weiss N., Dreweck C.M., Taylor H.R., Brotman B., Schulz-Key H., Greene B.M. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus. Exp. Parasitol. 1992, 74:367-380.
134. Stewart G.R., Elson L., Araujo E., Guderian R., Nutman T.B., Bradley J.E. Isotype-specific characterization of antibody responses to Onchocerca volvulus in putatively immune indivi-duals. Parasite Immunol. 1995, 17:371-380.
135. Tawe W., Pearlman E., Unnasch T.R., Lustigman S. Angiogenic activity of Onchocerca volvulus recombinant proteins similar to vespid venom antigen 5. Mol. Biochem. Parasitol. 2000, 109:91-99.
136. Taylor M.J. Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:596-598.
137. Taylor M.J., Abdel-Wahab N., Wu Y., Jenkins R.E., Bianco A.E. Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis. Infect. Immun. 1995, 63:4417-4422.
138. Taylor M.J., Cross H.F., Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J. Exp. Med. 2000, 191:1429-1436.
139. Taylor M.J., Makunde W.H., McGarry H.F., Turner J.D., Mand S., Hoerauf A. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet 2005, 365:2116-2121.
140. Taylor M.J., van Es R.P., Shay K., Folkard S.G., Townson S., Bianco A.E. Protective immunity against Onchocerca volvulus and O. lienalis infective larvae in mice. Trop. Med. Parasitol. 1994, 45:17-23.
141. Tchakoute V.L., Graham S.P., Jensen S.A., Makepeace B.L., Nfon C.K., Njongmeta L.M., Lustigman S., Enyong P.A., Tanya V.N., Bianco A.E., Trees A.J. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5971-5976.
142. The African Programme for Onchocerciasis Control (APOC). Final communiqué of the 11th session of the Joint Action Forum (JAF) of APOC, Paris, France, 6-9 December, 2005. Ouagadougou (Burkina Faso), 2005.
143. Tielsch J.M., Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Trop. Med. Int. Health 2004, 9:A45-A56.
144. Townson S., Bianco A.E. Immunization of calves against the microfilariae of Onchocerca lienalis. J. Helminthol. 1982, 56:297-303.
145. Townson S., Bianco A.E. Experimental infection of mice with the microfilariae of Onchocerca lienalis. Parasitology 1982, 85:283-293.
146. Townson S., Bianco A.E., Doenhoff M.J., Muller R. Immunity to Onchocerca lienalis microfilariae in mice. I. Resistance induced by the homologous parasite. Tropenmed. Parasitol. 1984, 35:202-208.
147. Townson S., Nelson G.S., Bianco A.E. Immunity to Onchocerca lienalis microfilariae in mice. II. Effects of sensitization with a range of heterologous species. J. Helminthol. 1985, 59:337-346.
148. Trees A.J., Graham S.P., Renz A., Bianco A.E., Tanya V. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Parasitology 2000, 120:S133-S142.
149. Trees A.J., Wahl G., Klager S., Renz A. Age-related differences in parasitosis may indicate acquired immunity against microfilariae in cattle naturally infected with Onchocerca ochengi. Parasitology 1992, 104:247-252.
150. Tsuji N., Miyoshi T., Islam M.K., Isobe T., Yoshihara S., Arakawa T., Matsumoto Y., Yokomizo Y. Recombinant Ascaris 16-kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs. J. Infect. Dis. 2004, 190:1812-1820.
151. Tsuji N., Suzuki K., Kasuga-Aoki H., Isobe T., Arakawa T., Matsumoto Y. Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infect. Immun. 2003, 71:5314-5323.
152. Tsuji N., Suzuki K., Kasuga-Aoki H., Matsumoto Y., Arakawa T., Ishiwata K., Isobe T. Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice. Infect. Immun. 2001, 69:7285-7292.
153. Turaga P.S., Tierney T.J., Bennett K.E., McCarthy M.C., Simonek S.C., Enyong P.A., Moukatte D.W., Lustigman S. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens. Infect. Immun. 2000, 68:1905-1911.
154. van Der Kleij D., Tielens A.G., Yazdanbakhsh M. Recognition of schistosome glycolipids by immunoglobulin E: possible role in immunity. Infect. Immun. 1999, 67:5946-5950.
155. Wahl G., Achu-Kwi M.D., Mbah D., Dawa O., Renz A. Bovine onchocercosis in north Cameroon. Vet. Parasitol. 1994, 52:297-311.
156. Wahl G., Enyong P., Ngosso A., Schibel J.M., Moyou R., Tubbesing H., Ekale D., Renz A. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca vo-lvulus in man. Parasitology 1998, 116:349-362.
157. Wang S.H., Zheng H.J., Dissanayake S., Cheng W.F., Tao Z.H., Lin S.Z., Piessens W.F. Evaluation of recombinant chitinase and SXP1 antigens as antimicrofilarial vaccines. Am. J. Trop. Med. Hyg. 1997, 56:474-481.
158. Ward D.J., Nutman T.B., Zea-Flores G., Portocarrero C., Lujan A., Ottesen E.A. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J. Infect. Dis. 1988, 157:536-543.
159. Weiss N., van Den Ende M.C., Albiez E.J., Barbiero V.K., Forsyth K., Prince A.M. Detection of serum antibodies and circulating antigens in a chimpanzee experimentally infected with Onchocerca volvulus. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:587-591.
160. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ. Tech. Rep. Ser. 1995, 852:1-104. WHO.
161. WHO. Onchocerciasis: strategic direction for research. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ. Tech. Rep. Ser. 2002.
162. Williams S.A., Laney S.J., Lizotte-Waniewski M., Bierwert L.A., Unnasch T.R. The River Blindness Genome Project. Trends Parasitol. 2002, 18:86-90.
163. Winnen M., Plaisier A.P., Alley E.S., Nagelkerke N.J., van Oortmarssen G., Boatin B.A., Habbema J.D. Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bull. World Health Organ. 2002, 80:384-391.
164. Wu Y., Adam R., Williams S.A., Bianco A.E. Chitinase genes expressed by infective larvae of the filarial nematodes, Acanthocheilonema viteae and Onchocerca volvulus. Mol. Biochem. Parasitol. 1996, 75:207-219.
165. Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., Trezza R.P., Heinzel F.P., Forsthuber T., Lehmann P.V. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 1999, 162:3942-3949.
166. Zhan B., Wang Y., Liu Y., Williamson A., Loukas A., Hawdon J.M., Xue H.C., Xiao S.H., Hotez P.J. Ac-SAA-1, an immunodominant 16 kDa surface-associated antigen of infective larvae and adults of Ancylostoma caninum. Int. J. Parasitol. 2004, 34:1037-1045.
167. Zimmerman P.A., Guderian R.H., Aruajo E., Elson L., Phadke P., Kubofcik J., Nutman T.B. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J. Infect. Dis. 1994, 169:686-689.